Innovation Transformed into Vaccines
The President and Mrs. Bush cordially invited JN for Malaria Awareness Day Wednesday, April 25, 2007 at the The White House & Rose Garden
JN/GBC Contribution on Prevention of Malaria in Zambia
JN the founder of the biotechnology industry, is a company with a decade track record of delivering on the promise of biotechnology. Today, JN is among the world's leading biotech companies, with innovated diagnostics and vaccine products for detection and prevention of the most common diseases. With its strength in all areas of the product development process - from research to manufacturing and commercialization - JN continues to transform the possibilities of biotechnology into improved realities for human health.
PLEASE BACK TO GLOBAL HEALTH PAGE